Pure Biologics S.A.

Equities

PUR

PLPRBLG00010

Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 11:55:42 2024-05-13 am EDT			5-day change	1st Jan Change
7.3 ^PLN	+0.69%		-5.93%	-42.25%

2023	Pure Biologics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Pure Biologics S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Pure Biologics Spólka Akcyjna announced that it has received €6.7 million in funding from National Centre for Research and Development

August 20, 2019

Pure Biologics Spólka Akcyjna (WSE:PUR) announced that it has received €6.7 million in a round of funding on August 21, 2019. The transaction included participation from National Centre for Research and Development.

Latest news about Pure Biologics S.A.

Pure Biologics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 15	CI
Pure Biologics S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Presage Announces Collaboration with Pure Biologics to Investigate Oncology Agents in Early Development with CIVO® Technology	23-02-06	CI
Dom Maklerski Navigator S.A. and IPOPEMA Securities S.A. agreed to acquire an unknown minority stake in Pure Biologics Spólka Akcyjna.	22-12-12	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-15	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-16	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Pure Biologics Sp?lka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-10	CI
Pure Biologics Spólka Akcyjna announced that it has received €6.7 million in funding from National Centre for Research and Development	19-08-20	CI
Pure Biologics Spólka Akcyjna announced that it has received PLN 10.1 million in funding	19-04-23	CI

Chart Pure Biologics S.A.

Duration

Period

More charts

Company Profile

Pure Biologics SA is a manufacturer of biological products. The Company was founded in August 2010 and is located in Wroclaw, Poland.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
PURE BIOLOGICS S.A.	-42.25%	6.12M
MODERNA, INC.	+26.37%	48.16B
IQVIA HOLDINGS INC.	-1.01%	41.73B
LONZA GROUP AG	+46.00%	41.03B
CELLTRION, INC.	-5.31%	28.77B
ICON PUBLIC LIMITED COMPANY	+9.34%	25.59B
ALNYLAM PHARMACEUTICALS, INC.	-21.69%	18.96B
BIO-TECHNE CORPORATION	+6.23%	12.92B
MEDPACE HOLDINGS, INC.	+26.99%	12.03B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.38%	11.77B

Other Biotechnology & Medical Research